Close Menu
    Facebook X (Twitter) Instagram
    ScoopSquare24
    • Home
    • News
    • AI
    • Crypto
    • Finance
    • Stocks
    Facebook X (Twitter) Instagram
    ScoopSquare24
    Home»News»Stocks»Morgan Stanley Downgrades Kering (PRTP) Stock Amid Gucci Turnaround Doubts
    Stocks

    Morgan Stanley Downgrades Kering (PRTP) Stock Amid Gucci Turnaround Doubts

    Oli DaleBy Oli DaleApril 13, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    TLDR

    • Morgan Stanley downgraded Kering from “overweight” to “equal-weight,” reducing the price target from €330 to €320.
    • Shares declined more than 3% Monday in response to the rating change.
    • Analysts noted the stock’s year-to-date outperformance has already captured most potential gains.
    • First-quarter 2026 sales at flagship brand Gucci are now expected to fall 6.2% — a steeper decline than previously anticipated.
    • The rating cut arrives just before Kering releases Q1 2026 results on April 14 and hosts its Capital Markets Day on April 16.

    Shares of Kering stumbled Monday after Morgan Stanley withdrew its bullish stance on the French luxury conglomerate, revising its outlook just ahead of critical financial disclosures.


    PPX.DE Stock Card
    Kering S.A., PPX.DE

    The investment bank shifted its recommendation from “overweight” to “equal-weight” while reducing its 12-to-18-month target from €330 to €320. The announcement sent shares tumbling more than 3% during trading.

    Morgan Stanley’s rationale centered on valuation: Kering had outpaced competitors including LVMH, Hermès, and Richemont by 300 to 1,700 basis points year-to-date. According to the firm, this significant advance has already captured the bulk of potential upside.

    “Our DCF implies 15% upside to the shares, which no longer translates into relative outperformance,” the bank stated in its research note.

    The shares peaked at €320.50 on January 12 before retreating approximately 16% through Monday’s session. A substantial 10.90% rally on February 10 — the period’s strongest single-day performance — was largely erased by consecutive declines of 5.04% and 6.35% on March 2 and 3.

    Gucci Remains the Core Challenge

    The iconic Italian label continues to pose the primary obstacle. Morgan Stanley’s updated forecast anticipates Gucci sales contracting 6.2% during Q1 2026, representing a deterioration from the previous 5% decline estimate. Looking ahead, analysts project Gucci revenue of €5.95 billion for full-year 2026, expanding to €7.67 billion by 2028.

    The firm characterized the situation candidly: “a classic case where improving buzz is running ahead of the hard numbers.” Channel feedback from European retailers revealed “early signs of improving brand buzz but little evidence yet of a meaningful commercial recovery.”

    The more pessimistic projection also reflects weaker first-quarter channel intelligence and Kering’s vulnerability to Middle Eastern geopolitical tensions, representing approximately 5% of consolidated revenue.

    Critical Timing and Forward Outlook

    The downgrade arrives at a pivotal juncture. Kering is scheduled to release Q1 2026 financial results on April 14, immediately followed by its Capital Markets Day on April 16. These presentations will determine whether management’s turnaround narrative resonates with investors.

    Morgan Stanley lowered its 2028 earnings per share projection by 4% to €15.97, though this remains 15% above the Visible Alpha consensus of €13.80. At current levels, the stock trades at approximately 17 times forward earnings.

    Analysts forecast group-wide revenue reaching €18.3 billion by 2028, representing roughly 25% growth from 2025’s €14.7 billion. Consolidated operating margins are expected to climb from 12.5% in 2026 to 18.4% by 2028.

    Morgan Stanley’s optimistic scenario targets €480, predicated on a Gucci super-cycle driving group margins to 25.9% in 2028. The pessimistic scenario envisions €175, assuming the brand’s new creative direction fails commercially. Current options pricing suggests approximately 28.9% probability of exceeding €320 within twelve months, versus 17.1% odds of dropping below €175.

    The firm identified two potential catalysts for upgrading: continued operational improvements under CEO Luca de Meo, appointed in September 2025, and tangible proof of Gucci’s commercial resurgence.

    Notably, Morgan Stanley had elevated Kering in October 2025, designating it among top European luxury picks while praising the sector’s “burst of creativity.” Monday’s action represents a complete reversal from that optimistic assessment.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Oli Dale
    • Website

    Related Posts

    Allogene Therapeutics (ALLO) Stock Rockets 41% on Breakthrough Lymphoma Trial Results

    April 13, 2026

    Broadcom (AVGO) Stock Surges on Extended Google TPU Deal and Raised AI Revenue Projections

    April 13, 2026

    Bitmine (BMNR) Stock Surges Past $11.8B in Total Assets Following NYSE Upgrade

    April 13, 2026
    Leave A Reply Cancel Reply

    Breaking News
    Coincentral

    UK Sets 2027 Deadline as FCA Expands Reach Into DeFi and Crypto Firms

    Coincentral
    Apr 13, 2026 3:30 PM
    Blockonomi

    The Monero Price Prediction Everyone Is Reading While Pepeto Quietly Fills the Presale Smart Money Found First

    Blockonomi
    Apr 13, 2026 3:30 PM
    Moneycheck

    Allogene Therapeutics (ALLO) Stock Soars 41% Following Promising CAR T Clinical Results

    Moneycheck
    Apr 13, 2026 3:29 PM
    Parameter

    Allogene Therapeutics (ALLO) Stock Jumps 41% Following Strong ALPHA3 Trial Results

    Parameter
    Apr 13, 2026 3:25 PM
    Parameter

    Broadcom (AVGO) Stock Climbs as Google Deal Drives Analysts to Raise AI Revenue Projections

    Parameter
    Apr 13, 2026 3:24 PM
    Blockonomi

    Allogene Therapeutics (ALLO) Stock Soars 41% Following Breakthrough CAR T-Cell Trial Results

    Blockonomi
    Apr 13, 2026 3:22 PM
    Blockonomi

    Aeluma (ALMU) Stock Rockets 46% on $4M Federal Quantum Tech Contracts

    Blockonomi
    Apr 13, 2026 3:20 PM
    Moneycheck

    Aeluma (ALMU) Stock Soars 46% Following $4M Federal Contracts for Quantum Technology Development

    Moneycheck
    Apr 13, 2026 3:18 PM
    Moneycheck

    European Central Bank Endorses ESMA’s Direct Supervision Plan for Binance and Coinbase

    Moneycheck
    Apr 13, 2026 3:15 PM
    Moneycheck

    Broadcom (AVGO) Stock Surges as Wall Street Raises AI Revenue Projections on Google Partnership

    Moneycheck
    Apr 13, 2026 3:15 PM
    Blockonomi

    Broadcom (AVGO) Stock Surges on Extended Google Partnership and Raised AI Revenue Projections

    Blockonomi
    Apr 13, 2026 3:14 PM
    Moneycheck

    South Korean Exchange Coinone Hit with $3.5M Fine Over AML Compliance Lapses

    Moneycheck
    Apr 13, 2026 3:14 PM
    Coincentral

    Aeluma, Inc. (ALMU) Stock: Surges 46% After $4M U.S. Government Contracts Boost Quantum Tech Push

    Coincentral
    Apr 13, 2026 3:09 PM
    Blockonomi

    Bitcoin L2s Are Quietly Becoming the Go-To Rails for Tokenized Real-World Assets

    Blockonomi
    Apr 13, 2026 3:08 PM
    Moneycheck

    US Launches Hormuz Blockade Targeting Iran Oil Exports as Gas Prices Surge Nationwide

    Moneycheck
    Apr 13, 2026 3:08 PM
    Facebook X (Twitter) Instagram Pinterest
    ScoopSquare24

    Copyright © 2013 - 2026 Kooc Media Ltd. All rights reserved. Registered Company No.05695741
    Our Sites: FlowPresets / GardenBeast / GolfMonster / Blockonomi / Money Check / CoinCentral / Parameter / Circlo / Computing.net

    Type above and press Enter to search. Press Esc to cancel.